Re: Editorial Comment on Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial (Eur Urol 2012; 61: 917–925): S. A. Kaplan J Urol 2013; 189: 1448–1449.

Abstract

No AccessJournal of UrologyLetter to the Editor/Errata1 Dec 2013Re: Editorial Comment on Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial (Eur Urol 2012; 61: 917–925)S. A. Kaplan J Urol 2013; 189: 1448–1449. Matthias Oelke Matthias OelkeMatthias Oelke Financial interest and/or other relationship with Apogepha, Astellas, GlaxoSmithKline, Eli Lilly and Co., and Recordati. More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.05.120AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: Editorial Comment on Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial (Eur Urol 2012; 61: 917–925)." The Journal of Urology, 190(6), pp. 2311–2312 References 1 : Tadalafil once daily improves ejaculatory function, erectile function and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) and erectile dysfunction (ED): results from a randomized, placebo- and tamsulosin-controlled 12-week double-blind study. J Sex Med2013; 10: 857. Google Scholar 2 : EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms, including benign prostatic obstruction. Eur Urol2013; 64: 118. Google Scholar © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 190Issue 6December 2013Page: 2311-2312 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Matthias Oelke Financial interest and/or other relationship with Apogepha, Astellas, GlaxoSmithKline, Eli Lilly and Co., and Recordati. More articles by this author Expand All Advertisement PDF downloadLoading ...